E-LIB Suche - Ergebnisse für: Howes, O.D.

1

Cerebral blood flow in treatment resistant schizophrenia an..:

Sun, J. ; Zelaya, F. ; Sendt, K.V....
Neuroscience Applied. 3 (2024) - p. 103949 , 2024

Link: https://doi.org/10.1016/..

2

CLEAR – clozapine in early psychosis: study protocol for a ..:

Casetta, C. ; Santosh, P. ; Bayley, R....
BMC Psychiatry. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

The real-world use of mood stabilisers as an augmentation s..:

Butler, E. ; Kornblum, D. ; Howes, O..
Neuroscience Applied. 3 (2024) - p. 104007 , 2024

Link: https://doi.org/10.1016/..

4

Can enhancer-based partitioned polygenic risk scores improv..:

Osimo, E.F. ; Georgieva, R. ; Howes, O.D...
Neuroscience Applied. 2 (2023) - p. 103375 , 2023

Link: https://doi.org/10.1016/..

5

Sub-chronic ketamine administration increases dopamine synt..:

Petty, A. ; Garcia-Hidalgo, A. ; Barker-Halff, E....
Neuroscience Applied. 2 (2023) - p. 103307 , 2023

Link: https://doi.org/10.1016/..

6

The impact of severe mental illness (SMI) on the rate of CO..:

Hamakarim, T. ; Arumuham, A. ; Parmar, S..
European Psychiatry. 66 (2023) S1 - p. S454-S455 , 2023

Link: https://doi.org/10.1192/..

7

Subchronic amisulpride administration induces negative symp..:

Osugo, M. ; Zahid, U. ; Selvaggi, P....
Neuroscience Applied. 1 (2022) - p. 100094 , 2022

Link: https://doi.org/10.1016/..

8

Predicting treatment resistance in people with a first-epis..:

Osimo, E.F. ; Perry, B. ; Mallikarjun, P....
European Psychiatry. 65 (2022) S1 - p. S107-S107 , 2022

Link: https://doi.org/10.1192/..

9

Mitochondrial complex I availability is reduced in schizoph..:

Whitehurst, T. ; Onwordi, E. ; Mansur, A....
Neuroscience Applied. 1 (2022) - p. 100069 , 2022

Link: https://doi.org/10.1016/..

10

N-Methyl-D-Aspartate Receptor availability in First-Episode..:

Beck, K. ; Arumuham, A. ; Brugger, S....
European Psychiatry. 65 (2022) S1 - p. S77-S77 , 2022

Link: https://doi.org/10.1192/..

11

P.302 N-methyl-D-aspartate receptor availability in first-e..:

Beck, K. ; Arumuham, A. ; Veronese, M....
European Neuropsychopharmacology. 44 (2021) - p. S40 , 2021

Link: https://doi.org/10.1016/..

12

Tools for optimising pharmacotherapy in psychiatry (therape..:

Eap, C. B. ; Gründer, G. ; Baumann, P....
The World Journal of Biological Psychiatry. 22 (2021) 8 - p. 561-628 , 2021

Link: https://doi.org/10.1080/..

13

P.0586 Effects of cannabidiol (CBD) alone and combined with..:

Ertl, N. ; Wall, M. ; Pope, R....
European Neuropsychopharmacology. 53 (2021) - p. S429 , 2021

Link: https://doi.org/10.1016/..

14

P.0757 White-matter free-water diffusion MRI in schizophren..:

Figueiredo, I. Carreira ; Borgan, F. ; Pasternak, O...
European Neuropsychopharmacology. 53 (2021) - p. S551-S552 , 2021

Link: https://doi.org/10.1016/..

15

P.525 The relationship between synaptic density marker SV2A..:

Onwordi, E.C. ; Halff, E. ; Whitehurst, T....
European Neuropsychopharmacology. 40 (2020) - p. S296 , 2020

Link: https://doi.org/10.1016/..